Several independent groups of researchers have shown that an anti-ERVK Env vaccine is a promising cancer treatment as it has been effective in targeting several types of malignant tumors via the inhibition of tumor growth and induction of apoptosis (Downey et al., 2014). Here, ERVW-1 is linked to cancer.